236 related articles for article (PubMed ID: 8010734)
21. Importance of glycoproteins in human cancer.
Patel PS; Raval GN; Rawal RM; Patel MM; Balar DB; Patel DD
Indian J Biochem Biophys; 1997; 34(1-2):226-33. PubMed ID: 9343956
[TBL] [Abstract][Full Text] [Related]
22. Glycoproteins as markers of inflammation in rheumatic disorders.
Kulkarni AV; Engineer JJ; Sequira RD; Borges NE; Joshi VR
J Postgrad Med; 1986 Apr; 32(2):89-93. PubMed ID: 3761215
[No Abstract] [Full Text] [Related]
23. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
24. [Monitoring of minimal residual disease in patients with chronic myeloleukemia: clinical value of real-time polymerase chain reaction].
Chelysheva EIu; Turkina AG; Misiurin AV; Aksenova EV; Domracheva EV; Zakharova AV; Khoroshko ND
Ter Arkh; 2007; 79(4):49-53. PubMed ID: 17564019
[TBL] [Abstract][Full Text] [Related]
25. Circulating transferrin receptor in acute leukemias.
Kato J; Kohgo Y; Kondo H; Nishisato T; Sasaki K; Tsushima N; Hirayama M; Fujikawa K; Sintani N; Miyazaki E
Int J Hematol; 1992 Oct; 56(2):161-5. PubMed ID: 1421178
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of total and lipid bound sialic acid levels in oral pre-cancerous conditions and oral cancer.
Rajpura KB; Patel PS; Chawda JG; Shah RM
J Oral Pathol Med; 2005 May; 34(5):263-7. PubMed ID: 15817068
[TBL] [Abstract][Full Text] [Related]
27. Tumor M2-PK levels in haematological malignancies.
Oremek GM; Rox S; Mitrou P; Sapoutzis N; Sauer-Eppel H
Anticancer Res; 2003; 23(2A):1135-8. PubMed ID: 12820361
[TBL] [Abstract][Full Text] [Related]
28. [Usefulness of sialic acid as a tumor marker].
Feliú J; Daimiel E; Vicente J; Martín G; García Girón C; Chacón I; González Barón M
Rev Clin Esp; 1989 May; 184(8):401-3. PubMed ID: 2781072
[TBL] [Abstract][Full Text] [Related]
29. Study of serum fucose and serum sialic acid levels in oral squamous cell carcinomia.
Shashikanth MC; Rao BB
Indian J Dent Res; 1994; 5(4):119-24. PubMed ID: 9495093
[TBL] [Abstract][Full Text] [Related]
30. Relation between raised concentrations of fucose, sialic acid, and acute phase proteins in serum from patients with cancer: choosing suitable serum glycoprotein markers.
Turner GA; Skillen AW; Buamah P; Guthrie D; Welsh J; Harrison J; Kowalski A
J Clin Pathol; 1985 May; 38(5):588-92. PubMed ID: 2582003
[TBL] [Abstract][Full Text] [Related]
31. Correlation of serum sialic acid fractions as markers for carcinoma of the uterine cervix.
Lagana A; Martinez BP; Marino A; Fago G; Bizzarri M
Anticancer Res; 1995; 15(5B):2341-6. PubMed ID: 8572649
[TBL] [Abstract][Full Text] [Related]
32. [Serum sialic acid levels in patients with acute prostatitis or acute epididymitis].
Ohkawa M; Okasho A; Fuse H; Orito M; Sugata T; Hisazumi H
Hinyokika Kiyo; 1985 Dec; 31(12):2161-8. PubMed ID: 3832918
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of acute and chronic leukemias].
Mandelli F; Montefusco E
Recenti Prog Med; 1999 Nov; 90(11):605-12. PubMed ID: 10608151
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric assay of phosphotyrosine levels in Bcr-Abl-positive chronic myelogenous leukemias: a potential prognostic marker.
Sun X; Li J; Chen J; Li D; Chen L; Xu W; Yang Y; Wu Y; Jiang P; Xie W
Ann Hematol; 2009 Jan; 88(1):29-36. PubMed ID: 18696070
[TBL] [Abstract][Full Text] [Related]
35. [Sialic acid--an acute phase reactant and a concomitant of tumors].
Simmich T; Dehne A; Laube K; Laube N; Frank KH
Z Med Lab Diagn; 1991; 32(3-4):188-92. PubMed ID: 1897297
[TBL] [Abstract][Full Text] [Related]
36. Methylation of histones in myeloid leukemias as a potential marker of granulocyte abnormalities.
Lukásová E; Koristek Z; Falk M; Kozubek S; Grigoryev S; Kozubek M; Ondrej V; Kroupová I
J Leukoc Biol; 2005 Jan; 77(1):100-11. PubMed ID: 15507473
[TBL] [Abstract][Full Text] [Related]
37. Serum sialic acid--an important cancer marker.
Tewarson SL; Mittal VP; Singh M; Gupta GP
Indian J Cancer; 1993 Sep; 30(3):125-31. PubMed ID: 8300142
[TBL] [Abstract][Full Text] [Related]
38. [Distribution characteristics and normal values of protein-bound carbohydrates].
Iakovleva VP; Nikolaenko LA
Lab Delo; 1980; (3):177-8. PubMed ID: 6155528
[No Abstract] [Full Text] [Related]
39. Malondialdehyde and protein carbonyl as biomarkers for oxidative stress and disease progression in patients with chronic myeloid leukemia.
Ahmad R; Tripathi AK; Tripathi P; Singh S; Singh R; Singh RK
In Vivo; 2008; 22(4):525-8. PubMed ID: 18712183
[TBL] [Abstract][Full Text] [Related]
40. [Value of serum sialic acid determination in children].
Seider A; Graf N; Sitzmann FC
Padiatr Padol; 1992; 27(2):43-6. PubMed ID: 1603602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
